I now have comprehensive, authoritative data from Campbell Walsh Urology and Symptom to Diagnosis. Let me compile a full, well-structured answer.
Investigation Algorithm: Painless Hematuria in a 55-Year-Old Man
Why This Presentation Demands Urgent Attention
Painless hematuria in a man over 40 is bladder urothelial carcinoma until proven otherwise. In patients presenting to hematuria clinics with gross hematuria:
- 20-25% have bladder cancer
- 1.3-10% have prostate cancer
- 0.6-2% have renal cell carcinoma
- ~21% have stones
- 12-13% have BPH
The overall risk of malignancy in gross hematuria is 20.4%. Even a single episode of gross hematuria must be fully evaluated - do not be reassured by a negative subsequent urinalysis. Anticoagulant therapy does not eliminate the need for full workup. - Campbell Walsh Wein Urology
Step 1 - Confirm True Hematuria
Urine dipstick is sensitive (91-100%) but poorly specific (65%) due to cross-reactivity with hemoglobin and myoglobin. It must always be confirmed with:
- Microscopic urinalysis (UA with microscopy): the gold standard. Confirms hematuria as ≥3 RBCs/hpf. A single positive microscopic UA is sufficient to prompt full evaluation.
- If dipstick is positive but no RBCs on microscopy, consider myoglobinuria (rhabdomyolysis) or hemoglobinuria (hemolysis).
- If urine is red/brown but UA is normal, consider pigmenturia: beets, rifampin, phenazopyridine, porphyrins.
Step 2 - Initial Assessment (History, Exam, Basic Labs)
History - risk stratification for malignancy:
| Risk Factor | Significance |
|---|
| Age >40, male sex | High-risk demographic for bladder cancer |
| Smoking (current or former) | Single most important modifiable risk factor for bladder cancer |
| Occupational exposures | Aromatic amines, aniline dyes, rubber, leather, mining; 10-20 year latency |
| Cyclophosphamide/ifosfamide use | Hemorrhagic cystitis |
| Pelvic radiation history | Radiation cystitis |
| Analgesic abuse | Papillary necrosis |
| LUTS (frequency, urgency, nocturia) | BPH, prostatitis, or CIS of bladder |
| Flank pain | Calculus, RCC, obstruction |
| Family history of kidney disease | Hereditary nephritis, PKD |
| Medications | Anticoagulants, NSAIDs, cyclophosphamide |
Physical examination:
- Abdominal mass / renal ballottement (RCC, PKD)
- Digital rectal exam (DRE) - prostate size, nodularity, tenderness
- Bimanual exam if bladder tumor suspected
- Blood pressure (hypertension - glomerular disease, RCC)
- Signs of systemic disease (rash, arthritis, edema)
Basic blood tests:
- Full blood count
- Renal function (creatinine, eGFR, electrolytes)
- Coagulation screen (PT/INR, APTT)
- PSA - discuss with patient; ~10% of men with recurrent gross hematuria have prostate cancer - Campbell Walsh Wein Urology
Step 3 - Urine Studies
| Test | Indication | Notes |
|---|
| Urine microscopy | All patients | RBC morphology: dysmorphic RBCs / acanthocytes + casts = glomerular origin |
| Urine culture (MSU) | All patients | Exclude UTI before proceeding - treat if positive and repeat UA |
| Urine cytology | Gross hematuria | ~50% sensitivity for high-grade bladder cancer; adjunct to cystoscopy; not recommended for routine microhematuria workup |
| Urine biomarkers (NMP22, BladderChek, UroVysion FISH) | Gross hematuria | Higher sensitivity than cytology for low-grade tumors; used adjunctively |
| Protein:creatinine ratio | If proteinuria present | Points toward glomerular disease |
Key decision point on UA microscopy:
- Dysmorphic RBCs + RBC casts + proteinuria → glomerular hematuria pathway → nephrology referral (± renal biopsy)
- Normal RBC morphology, no casts, no significant proteinuria → non-glomerular / lower urinary tract pathway → urological workup
Step 4 - Imaging
For gross hematuria in a 55-year-old man:
CT Urogram (CTU) - First-Line Imaging
- Multi-phase CT scan: non-contrast phase + nephrographic phase + excretory/delayed phase (opacifies the pelvicalyceal system, ureters, and bladder)
- Sensitivity 92-100% and specificity 94-97% for renal masses, urinary tract stones, and urothelial carcinomas
- Has largely replaced IVP (intravenous pyelogram), plain renal ultrasound alone, and conventional CT for hematuria workup
- Radiation dose is significant - justified in high-risk patients
- If CTU is done first, it may improve the sensitivity of subsequent cystoscopy
Note: Renal/bladder ultrasound alone may suffice for asymptomatic microhematuria in lower-risk patients, but for gross hematuria in a 55-year-old man, CTU is the standard.
Step 5 - Cystoscopy
White-light flexible cystoscopy is the gold standard for diagnosing bladder cancer. It is mandatory in any adult with gross hematuria not explained by infection.
- Direct visualisation of the entire bladder urothelium and urethra
- Random cold-cup biopsies taken to detect carcinoma in situ (CIS), which is flat and not visible to the naked eye
- Hexaminolevulinate (HAL) fluorescence cystoscopy ("blue light" cystoscopy): photosensitiser instilled intravesically; cancer cells fluoresce red under blue light - improves CIS detection
- If bladder tumour found, transurethral resection of bladder tumour (TURBT) is performed for diagnosis and staging
- Bimanual examination under anaesthesia at time of TURBT assesses for muscle invasion
Diagnostic Algorithm Summary
Figure: Diagnostic approach to visible (gross) hematuria - Symptom to Diagnosis, 4th ed.
Adapted for a 55-year-old man with painless hematuria:
Painless gross hematuria
│
▼
Confirm with UA microscopy (≥3 RBCs/hpf)
│
├─── Dipstick+ but no RBCs → Myoglobinuria / Hemoglobinuria
│
▼
Urine culture (MSU)
│
├─── Positive → Treat UTI → Repeat UA → if resolved, stop
│ if persistent → full workup
│
▼
Check UA for proteinuria / RBC casts / dysmorphic RBCs
│
├─── Yes (glomerular features) → Nephrology referral
│ ± Renal biopsy
│
▼ (No glomerular features)
UROLOGY WORKUP (Simultaneous)
┌─────────────────────────┐
│ CT Urogram │ ← Upper tract + bladder imaging
│ Flexible Cystoscopy │ ← Lower tract, gold standard
│ Urine Cytology │ ← Adjunct for urothelial cancer
│ PSA │ ← Prostate cancer
│ DRE │ ← Prostate assessment
└─────────────────────────┘
│
├─── Bladder tumour → TURBT (diagnostic + therapeutic)
├─── Renal mass → Staging CT chest/abdomen/pelvis → Urology/Oncology
├─── Calculus → Urology (stone management)
├─── BPH → Urology management
├─── Prostate cancer → Urology/Oncology staging
└─── No cause found → Repeat evaluation at 3-5 years
Differential Diagnosis Table (55-Year-Old Male, Painless Hematuria)
| Diagnosis | Key Clues | Primary Test |
|---|
| Bladder cancer (leading) | Age >40, male, smoker, painless | Cystoscopy + CTU |
| Stone disease | Can be painless if not obstructing | Non-contrast CT |
| BPH | LUTS, elderly male | DRE, flow studies |
| Prostate cancer | Painless, abnormal DRE | PSA, DRE, biopsy |
| Renal cell carcinoma | Painless mass, weight loss | CT abdomen |
| Urothelial carcinoma of renal pelvis/ureter | Upper tract filling defect | CTU, ureteroscopy |
| Prostatitis | Pain, fever, tender prostate | DRE, MSU |
Key Principles
- Never attribute gross hematuria to anticoagulation alone - the underlying cause still requires exclusion
- Any single episode of gross hematuria in a man >40 requires full urological workup, even if the next UA is clear
- Urothelial cancer is a must-not-miss diagnosis in gross hematuria not due to infection - Symptom to Diagnosis, 4th ed.
- Glomerular features (dysmorphic RBCs, casts, heavy proteinuria) divert the workup toward nephrology
- If a full workup is negative, the risk of malignancy within 6 years is near zero; repeat evaluation can be deferred 3-5 years - Campbell Walsh Wein Urology